Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid for indirect hyperbilirubinemia in neonates receiving phototherapy
IRCT2017071515511N2Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ursodeoxycholic acid in Neonatal indirect hyperbilirubinemia (NIH), sponsored by Arak University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Neonatal indirect hyperbilirubinemia (NIH)
Beyond the preview
Go deeper on IRCT2017071515511N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017071515511N2.